A non-bioabsorbable, implantable bead/microsphere intended to be introduced into the peripheral vasculature during an interventional radiology procedure to treat hypervascularized tumours and arteriovenous malformation in a variety of anatomies (e.g., head, ne
| Company | Devices | Share |
|---|---|---|
| Biosphere Medical | 64 | 33% |
| Canyon Medical Inc. | 36 | 19% |
| Boston Scientific Corporation | 29 | 15% |
| Varian Medical Systems, Inc. | 26 | 14% |
| Microvention, Inc. | 15 | 8% |
| Cook Incorporated | 8 | 4% |
| Merit Medical Systems, Inc. | 7 | 4% |
| Abk Biomedical Incorporated | 6 | 3% |
| Biocompatibles Uk Ltd | 1 | 1% |
Company = labeler of record on GUDID. 9 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| KRD | Device, Vascular, For Promoting Embolization | 112 |
| KRD | Device, Vascular, for Promoting Embolization | 93 |
| NAJ | Agents, embolic, for treatment of uterine fibroids | 54 |
| NAJ | AGENTS,EMBOLIC,FOR TREATMENT OF UTERINE FIBROIDS | 46 |
| NAJ | Agents,Embolic,For Treatment Of Uterine Fibroids | 40 |
| NOY | Agents, embolic, for treatment of benign prostatic hyperplas | 37 |
Use these as the dimensions to specify in a tender line.
No closely related category with 50+ devices.
192 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Embolization particle, non-bioabsorbable", from 9 companies. The largest labeler is Biosphere Medical with 33% of records.
KRD (Device, Vascular, For Promoting Embolization), KRD (Device, Vascular, for Promoting Embolization), NAJ (Agents, embolic, for treatment of uterine fibroids), NAJ (AGENTS,EMBOLIC,FOR TREATMENT OF UTERINE FIBROIDS)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add embolization particle, non-bioabsorbable to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.